Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Haughey

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcomeC A Perez, M M Patel, K S Chao, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 26, 2010
Safety and pharmacokinetics of a novel lymphocyte function-associated antigen-1 antagonist ophthalmic solution (SAR 1118) in healthy adultsCharles P Semba, Dennis Swearingen, Valerie L Smith, et al.
Clinical Therapeutics|February 4, 2014
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteersSamuel S Dychter, Rena Harrigan, Jesse D Bahn, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcomeC A Perez, M M Patel, K S Chao, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 26, 2010
Safety and pharmacokinetics of a novel lymphocyte function-associated antigen-1 antagonist ophthalmic solution (SAR 1118) in healthy adultsCharles P Semba, Dennis Swearingen, Valerie L Smith, et al.
Clinical Therapeutics|February 4, 2014
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteersSamuel S Dychter, Rena Harrigan, Jesse D Bahn, et al.
Pageof 5